My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 164

    1.

    Diabetogenic potential of human pathogens uncovered in experimentally permissive beta-cells.

    Flodström M, Tsai D, Fine C, Maday A, Sarvetnick N.

    Diabetes. 2003 Aug;52(8):2025-34.PMID: 12882919 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Target cell expression of suppressor of cytokine signaling-1 prevents diabetes in the NOD mouse.

    Flodström-Tullberg M, Yadav D, Hägerkvist R, Tsai D, Secrest P, Stotland A, Sarvetnick N.

    Diabetes. 2003 Nov;52(11):2696-700.PMID: 14578288 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Target cell defense prevents the development of diabetes after viral infection.

    Flodström M, Maday A, Balakrishna D, Cleary MM, Yoshimura A, Sarvetnick N.

    Nat Immunol. 2002 Apr;3(4):373-82. Epub 2002 Mar 4.PMID: 11919579 [PubMed - indexed for MEDLINE]Related articles

    4.

    Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.

    Chong MM, Chen Y, Darwiche R, Dudek NL, Irawaty W, Santamaria P, Allison J, Kay TW, Thomas HE.

    J Immunol. 2004 May 1;172(9):5714-21.PMID: 15100317 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice.

    Solomon M, Flodström-Tullberg M, Sarvetnick N.

    Transplantation. 2005 May 15;79(9):1104-9.PMID: 15880051 [PubMed - indexed for MEDLINE]Related articles

    6.

    Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.

    von Herrath M, Holz A.

    J Autoimmun. 1997 Jun;10(3):231-8.PMID: 9218748 [PubMed - indexed for MEDLINE]Related articles

    7.

    SOCS-1 protects from virally-induced CD8 T cell mediated type 1 diabetes.

    Barral AM, Thomas HE, Ling EM, Darwiche R, Rodrigo E, Christen U, Ejrnaes M, Wolfe T, Kay TW, von Herrath MG.

    J Autoimmun. 2006 Nov;27(3):166-73. Epub 2006 Oct 10.PMID: 17045460 [PubMed - indexed for MEDLINE]Related articles

    8.

    Neither B lymphocytes nor antibodies directed against self antigens of the islets of Langerhans are required for development of virus-induced autoimmune diabetes.

    Holz A, Dyrberg T, Hagopian W, Homann D, von Herrath M, Oldstone MB.

    J Immunol. 2000 Nov 15;165(10):5945-53.PMID: 11067957 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Regulatory T-cells protect from type 1 diabetes after induction by coxsackievirus infection in the context of transforming growth factor-beta.

    Richer MJ, Straka N, Fang D, Shanina I, Horwitz MS.

    Diabetes. 2008 May;57(5):1302-11. Epub 2008 Feb 11.PMID: 18268045 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Absence of TNFRp55 influences virus-induced autoimmunity despite efficient lymphocytic infiltration.

    McKall-Faienza KJ, Kawai K, Kündig TM, Odermatt B, Bachmann MF, Zakarian A, Mak TW, Ohashi PS.

    Int Immunol. 1998 Apr;10(4):405-12.PMID: 9620596 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.

    Drescher KM, Kono K, Bopegamage S, Carson SD, Tracy S.

    Virology. 2004 Nov 24;329(2):381-94.PMID: 15518817 [PubMed - indexed for MEDLINE]Related articles

    12.

    Fas is detectable on beta cells in accelerated, but not spontaneous, diabetes in nonobese diabetic mice.

    Darwiche R, Chong MM, Santamaria P, Thomas HE, Kay TW.

    J Immunol. 2003 Jun 15;170(12):6292-7.PMID: 12794162 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection.

    Flodström-Tullberg M, Hultcrantz M, Stotland A, Maday A, Tsai D, Fine C, Williams B, Silverman R, Sarvetnick N.

    J Immunol. 2005 Feb 1;174(3):1171-7.PMID: 15661870 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus.

    von Herrath MG, Oldstone MB.

    J Exp Med. 1997 Feb 3;185(3):531-9.PMID: 9053453 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Autoreactive diabetogenic T-cells in NOD mice can efficiently expand from a greatly reduced precursor pool.

    Serreze DV, Johnson EA, Chapman HD, Graser RT, Marron MP, DiLorenzo TP, Silveira P, Yoshimura Y, Nathenson SG, Joyce S.

    Diabetes. 2001 Sep;50(9):1992-2000.PMID: 11522664 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice.

    von Herrath MG, Dyrberg T, Oldstone MB.

    J Clin Invest. 1996 Sep 15;98(6):1324-31.PMID: 8823297 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Type 1 diabetes: virus infection or autoimmune disease?

    Fairweather D, Rose NR.

    Nat Immunol. 2002 Apr;3(4):338-40. No abstract available. PMID: 11919574 [PubMed - indexed for MEDLINE]Related articles

    18.

    Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon.

    Serreze DV, Wasserfall C, Ottendorfer EW, Stalvey M, Pierce MA, Gauntt C, O'Donnell B, Flanagan JB, Campbell-Thompson M, Ellis TM, Atkinson MA.

    J Virol. 2005 Jan;79(2):1045-52.PMID: 15613333 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Protection from type 1 diabetes in the face of high levels of activated autoaggressive lymphocytes in a viral transgenic mouse model crossed to the SV129 strain.

    von Herrath MG, Wolfe T, Möhrle U, Coon B, Hughes A.

    Diabetes. 2001 Dec;50(12):2700-8.PMID: 11723052 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.

    Tracy S, Drescher KM, Chapman NM, Kim KS, Carson SD, Pirruccello S, Lane PH, Romero JR, Leser JS.

    J Virol. 2002 Dec;76(23):12097-111.PMID: 12414951 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity